PRF1 and neoplasm: In ADCC anti-GD2 mAbs engage Fcγ receptors on the surface of NK cells and granulocytes, followed by the release of cytotoxic granules (serine proteases and perforin, a glycoprotein that creates pores in cell membranes [30]), causing Fc dependent phagocytosis and lysis of tumor cells [31].